drugset / Trial / NCT01978600
Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate intraocular pressure (IOP) over a 24-hour period using Simbrinza™ topical ophthalmic suspension.
Timeline
- Start
- 2013-10
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brinzolamide 1%/Brimonidine 0.2% | Unknown | 0.2 % | Topical |
| Subject | Brinzolamide 1%/Brimonidine 0.2% | Unknown | 1 % | Topical |
| Comparator | Timolol | Other / unclassified | 0.5 % | Topical |